Second Sight Medical Prod... (EYES)
Company Description
As of August 30, 2022, Second Sight Medical Products, Inc. was acquired by Nano Precision Medical, Inc., in a reverse merger transaction.
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals.
It develops technologies to treat the population of sight-impaired individuals.
The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury.
The company was founded in 1998 and is headquartered in Sylmar, California.

Country | United States |
IPO Date | Nov 19, 2014 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 15 |
CEO | Matthew Pfeffer |
Contact Details
Address: 12744 San Fernando Rd Bldg 3 Sylmar, CALIFORNIA United States | |
Website | https://www.secondsight.com |
Stock Details
Ticker Symbol | EYES |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001266806 |
CUSIP Number | 81362J209 |
ISIN Number | US81362J2096 |
Employer ID | 00-0000000 |
SIC Code | 3845 |
Key Executives
No executives data available.Latest SEC Filings
Date | Type | Title |
---|---|---|
May 14, 2025 | 4 | Filing |
May 14, 2025 | 4 | Filing |
May 14, 2025 | 4 | Filing |
May 14, 2025 | 4 | Filing |
May 14, 2025 | 4 | Filing |
May 13, 2025 | 10-Q | Quarterly Report |
May 13, 2025 | 8-K | Current Report |
May 06, 2025 | DEFR14A | Filing |
Apr 29, 2025 | ARS | Filing |
Apr 29, 2025 | DEFA14A | Filing |